86.45 Delayed Data As of Apr 20 | ![]() Today’s Change | 45.11 Today|||52-Week Range 89.33 | +51.22% Year-to-Date |
Agios' Leukemia Drug Bodes Well for Growth & Strong Pipeline Apr 18 / Zacks.com - Paid Partner Content | Pharma M&A Active This Week: 4 Potential Buyout Targets Apr 13 / Zacks.com - Paid Partner Content |
The Zacks Analyst Blog Highlights: Agios Pharmaceuticals, BioMarin Pharmaceutical, Ve... Apr 16 / Zacks.com - Paid Partner Content | Agios Pharmaceuticals Shares Rise on Buyout Speculation Apr 10 / Zacks.com - Paid Partner Content |